The analyses of the five previously reported candidate variants in the genes SLC22A2, ERCC1 and ERCC2 did not show a statistically significant association with eGFR decline or CTCAE-AKI in this study’s cohort (Table S7). Here, ERCC1 is linked to acute kidney injury.